Abstract: A method, device and system for organizing media content on a computer-based system to form a playlist, wherein the device has access to a database with a plurality of music tracks and associated feature vectors including feature values representing different semantic characteristics of a music track, as well as metadata including at least one type of metadata record representing associated information about the respective music track. The playlist is determined based on a query from the client device that includes an input vector, and at least one input metadata record, using an additional similarity matrix representing a measure of similarity between different metadata records of the same type.

Abstract: Embodiments provide a method for preventing shutdowns in LNG facilities by removing heavy hydrocarbons from the inlet gas supply. According to an embodiment, there is provided an LNG facility treating pipeline quality natural gas that is contaminated with lubrication oil and low concentrations of heavy hydrocarbons. Due to contamination, the behavior of the pipeline quality natural gas is not properly predicted by thermodynamic modeling. In an embodiment, heavy hydrocarbons are removed by a drain system in a heat exchanger. In an embodiment, heavy hydrocarbons are removed by a treatment bed.

Abstract: Embodiments provide a method for preventing shutdowns in LNG facilities by removing heavy hydrocarbons from the inlet gas supply. According to an embodiment, there is provided an LNG facility treating pipeline quality natural gas that is contaminated with lubrication oil and low concentrations of heavy hydrocarbons. Due to contamination, the behavior of the pipeline quality natural gas is not properly predicted by thermodynamic modeling. In an embodiment, heavy hydrocarbons are removed by a drain system in a heat exchanger. In an embodiment, heavy hydrocarbons are removed by a treatment bed.

Abstract: Embodiments provide a method for preventing shutdowns in LNG facilities by removing heavy hydrocarbons from the inlet gas supply. According to an embodiment, there is provided an LNG facility treating pipeline quality natural gas that is contaminated with lubrication oil and low concentrations of heavy hydrocarbons. Due to contamination, the behavior of the pipeline quality natural gas is not properly predicted by thermodynamic modeling. In an embodiment, heavy hydrocarbons are removed by a drain system in a heat exchanger. In an embodiment, heavy hydrocarbons are removed by a treatment bed.

Abstract: A bush assembly for use with jointed members in a motor vehicle, the bush assembly comprising: an outer housing; an inner member including a semi-spherical portion; and a bushing comprising a plurality of segments of resilient material disposed between the outer housing and the inner member, and defining a semi-spherical cavity for receiving the semi-spherical portion; the outer housing comprising a first housing section having a first engagement formation, and a second housing section having a second engagement formation, wherein said first and second engagement formations are adapted to be inter-engaged to secure said housing sections and retain the bushing and at least the semi-spherical portion of the inner member within the outer housing. A method for producing the bush assembly involving the pre-loading of the bushing, desirably composed of polyurethane, is also disclosed.

Abstract: The present invention relates to phosphodiesterase 9A (PDE9A) for use as a marker for prostate cancer, and the use of PDE9A as a marker for diagnosing, detecting, monitoring or prognosticating prostate cancer or the progression of prostate cancer. The present invention also relates to a composition for diagnosing, detecting, monitoring or prognosticating prostate cancer or the progression of prostate cancer, a corresponding method and immunoassay, a method for diagnosing, monitoring or prognosticating hormone-resistant prostate cancer vs. hormone-sensitive prostate cancer, a corresponding immunoassay, a method of data acquisition, an immunoassay for diagnosing, detecting, monitoring or prognosticating prostate cancer or the progression of prostate cancer, a method of identifying an individual for eligibility for prostate cancer therapy, an immunoassay for stratifying an individual or cohort of individuals with a prostate cancer disease, an immunoassay for stratifying an individual with prostate cancer.

Abstract: In an electrical machine which has time-varying or position-varying disturbances in its output, signals representing the position and values of machine-related parameters are used to solve a model of the machine to calculate the phase currents which are required to minimize the disturbances. The model is able to provide solutions in the presence of limitations of some of the operating conditions of the machine, for example the supply voltage or the error in the signal representing the position.

Abstract: The present invention relates to phosphodiesterase 4D7 (PDE4D7) for use as a marker for malignant, hormone-sensitive prostate cancer, wherein the expression of the marker is increased when comparing the expression in malignant, hormone-sensitive prostate cancer tissue, to the expression in normal tissue or benign prostate tumor tissue, and the use of PDE4D7 as a diagnostic marker for malignant, hormone-sensitive prostate cancer. The present invention also relates to a composition for diagnosing, detecting, monitoring or prognosticating malignant, hormone-sensitive prostate cancer, a corresponding detection method, a method allowing to discriminate between a benign and malignant hormone-sensitive prostate cancer and a method of data acquisition, as well as corresponding immunoassays. The present invention also relates to a method of identifying an individual for eligibility for malignant, hormone-sensitive prostate cancer as well as an immunoassay for stratifying an individual with such prostate cancer.

Abstract: The present invention relates to phosphodiesterase 4D7 (PDE4D7) for use as a marker for prostate cancer, and the use of PDE4D7 as a marker for diagnosing, detecting, monitoring or prognosticating prostate cancer or the progression of prostate cancer. The present invention also relates to a composition for diagnosing, detecting, monitoring or prognosticating prostate cancer or the progression of prostate cancer, a corresponding method and immunoassay, a method for diagnosing, monitoring or prognosticating hormone-resistant prostate cancer vs.

Abstract: In an electrical machine which has time-varying or position-varying disturbances in its output, signals representing the position and values of machine-related parameters are used to solve a model of the machine to calculate the phase currents which are required to minimise the disturbances. The model is able to provide solutions in the presence of limitations of some of the operating conditions of the machine, for example the supply voltage or the error in the signal representing the position.

Abstract: The present invention relates to phosphodiesterase 4D7 (PDE4D7) for use as a marker for malignant, hormone-sensitive prostate cancer, wherein the expression of the marker is increased when comparing the expression in malignant, hormone-sensitive prostate cancer tissue, to the expression in normal tissue or benign prostate tumor tissue, and the use of PDE4D7 as a diagnostic marker for malignant, hormone-sensitive prostate cancer. The present invention also relates to a composition for diagnosing, detecting, monitoring or prognosticating malignant, hormone-sensitive prostate cancer, a corresponding detection method, a method allowing to discriminate between a benign and malignant hormone-sensitive prostate cancer and a method of data acquisition, as well as corresponding immunoassays. The present invention also relates to a method of identifying an individual for eligibility for malignant, hormone-sensitive prostate cancer as well as an immunoassay for stratifying an individual with such prostate cancer.

Abstract: The present invention relates to phosphodiesterase 9A (PDE9A) for use as a marker for prostate cancer, and the use of PDE9A as a marker for diagnosing, detecting, monitoring or prognosticating prostate cancer or the progression of prostate cancer. The present invention also relates to a composition for diagnosing, detecting, monitoring or prognosticating prostate cancer or the progression of prostate cancer, a corresponding method and immunoassay, a method for diagnosing, monitoring or prognosticating hormone-resistant prostate cancer vs. hormone-sensitive prostate cancer, a corresponding immunoassay, a method of data acquisition, an immunoassay for diagnosing, detecting, monitoring or prognosticating prostate cancer or the progression of prostate cancer, a method of identifying an individual for eligibility for prostate cancer therapy, an immunoassay for stratifying an individual or cohort of individuals with a prostate cancer disease, an immunoassay for stratifying an individual with prostate cancer.

Abstract: The present invention relates to phosphodiesterase 4D7 (PDE4D7) for use as a marker for prostate cancer, and the use of PDE4D7 as a marker for diagnosing, detecting, monitoring or prognosticating prostate cancer or the progression of prostate cancer. The present invention also relates to a composition for diagnosing, detecting, monitoring or prognosticating prostate cancer or the progression of prostate cancer, a corresponding method and immunoassay, a method for diagnosing, monitoring or prognosticating hormone-resistant prostate cancer vs.

Abstract: A novel protein which has an activity to transport hydantoin compounds is described, as well as a recombinant expressing this transporter protein. From Microbacterium liquefaciens strain AJ3912, a novel gene was discovered to encode a protein which is able to transport hydantoin compounds. A recombinant with an excellent ability to uptake hydantoin compounds is obtained by introducing and expressing the novel gene, called mhp, using gene recombination techniques.

Abstract: A novel protein which has an activity to transport hydantoin compounds is described, as well as a recombinant expressing this transporter protein. From Microbacterium liquefaciens strain AJ3912, a novel gene was discovered to encode a protein which is able to transport hydantoin compounds. A recombinant with an excellent ability to uptake hydantoin compounds is obtained by introducing and expressing the novel gene, called mhp, using gene recombination techniques.

Abstract: A novel protein which has an activity to transport hydantoin compounds is described, as well as a recombinant expressing this transporter protein. From Microbacterium liquefaciens strain AJ3912, a novel gene was discovered to encode a protein which is able to transport hydantoin compounds. A recombinant with an excellent ability to uptake hydantoin compounds is obtained by introducing and expressing the novel gene, called mhp, using gene recombination techniques.

Abstract: A method of using a mobile device to determine movement, relative to the mobile device, of a print medium configured to be printed on by the mobile device in a print direction, the mobile device including a printer, a first sensor and processing means, the print medium comprising a substrate defining first and second opposite faces, the first face bearing coded data, the method comprising the steps of: using the first sensor to sense at least some of the coded data from the print medium; determining movement of the print medium relative to sensor, based on the coded data sensed by the first sensor.